No Data
ch innovation [01217] is now trading at 0.013 Hong Kong dollars, with a rise of 18.18%.
As of 11:32, ch innovation [01217] reported 0.013 Hong Kong dollars, up 0.002 Hong Kong dollars or 18.18% from the previous closing price of 0.011 Hong Kong dollars, with a transaction amount of 0.2593 million Hong Kong dollars. The highest price today was 0.013 Hong Kong dollars, and the lowest price was 0.011 Hong Kong dollars. Based on the previous closing price, the 10-day average price is 0.01 Hong Kong dollars, and the 50-day average price is 0.01 Hong Kong dollars. The current pe ratio is 55.00 times, and the 14-day relative strength index is 21.43.
ch innovation (01217) had a net asset value per share of approximately 0.045 Hong Kong dollars at the end of September.
ch innovation (01217) announced that, as of September 30, 2024, the unaudited earnings per share...
ch innovation (01217) terminates the investment management agreement with Evergrande Securities.
Ch innovation (01217) announced that Evergrande Securities has notified the company on September 11, 2024...
Ch innovation investment acquires over 16% equity of Yi Life and becomes a major shareholder.
On September 15, Gelunhui reported that elife hldgs (0223.HK) announced its plan to offer 0.226 billion new shares to ch innovation (1217.HK), accounting for 16.66% of the enlarged share capital; the subscription price per share is 0.123 Hong Kong dollars, at a 12.14% discount to the closing price of 0.14 Hong Kong dollars last Friday, raising 27.798 million Hong Kong dollars. The company stated that the net proceeds from the subscription will be used to supplement the group's operating capital and develop the group's business. After completion, ch innovation will hold approximately 16.66% of the total number of issued shares of elife hldgs and become the main shareholder.
elife hldgs (00223) plans to issue 0.226 billion shares for subscription to ch innovation (01217).
E-life Holdings (00223) announced that on September 15, 2024, the company and the subscriber China Innovation Investment...
CH INNOVATION: 2024 Interim Report
No Data
No Data